Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Gastroenterology

What Do High Gastrin Levels Mean in Autoimmune Gastritis?

At a Glance

In autoimmune gastritis, high gastrin levels occur because the body is trying to compensate for low stomach acid. While not immediately dangerous, chronic high gastrin can increase the risk of slow-growing stomach growths called Type 1 gNETs, making regular endoscopy monitoring essential.

In autoimmune gastritis (AIG), discovering you have extremely high gastrin levels can be alarming, but it is a predictable part of how this condition affects your body. Your high gastrin level is simply a sign that your body is trying to correct a lack of stomach acid [1]. While not immediately dangerous, it is an important marker that helps your doctors understand what is happening in your stomach and what to monitor for in the future [2].

The Acid and Gastrin Feedback Loop

To understand why your gastrin levels are so high, it helps to look at how the stomach normally functions. Your stomach contains specialized cells called parietal cells, which are responsible for producing stomach acid [1]. This acid is necessary for breaking down food and absorbing nutrients.

In autoimmune gastritis, your immune system mistakenly attacks these parietal cells, leading to their destruction over time [1]. As these cells are lost, your stomach’s ability to produce acid drops significantly—a condition known as achlorhydria or hypochlorhydria [2].

Your body detects this lack of acid and tries to fix it by releasing a hormone called gastrin [3][4]. Normally, gastrin tells the parietal cells to pump out more acid [1]. But because the parietal cells have been damaged by the autoimmune attack, they cannot respond [1]. The body, still sensing low acid, continues to pump out more and more gastrin in a futile attempt to stimulate acid production [1]. This continuous loop leads to the extremely high levels of gastrin seen on your blood test [4][2].

Is High Gastrin Dangerous?

High gastrin in itself is not an acute emergency or immediately dangerous [2]. It is primarily a diagnostic clue that tells your doctor your stomach is not producing enough acid, which is a characteristic feature of autoimmune gastritis [2][4]. Your care team can use your gastrin levels, sometimes alongside other markers like chromogranin A, to monitor the condition over time [3][5].

The Long-Term Connection to Gastric Neuroendocrine Tumors (gNETs)

While high gastrin is not an immediate threat, chronic (long-term) high levels of gastrin do carry a specific risk over time [6][7].

Gastrin doesn’t just tell parietal cells to make acid; it also stimulates another type of cell in your stomach called enterochromaffin-like (ECL) cells [8][9]. When these ECL cells are constantly bombarded by high levels of gastrin, they begin to multiply and grow in size—a process called ECL cell hyperplasia [8][10][11].

Over many years, this constant stimulation and overgrowth of ECL cells can lead to the development of small growths known as Type 1 gastric neuroendocrine tumors (gNETs) [12][6][9].

It is very important to understand that hearing the word “tumor” can be frightening, but Type 1 gNETs are generally slow-growing, highly treatable, and have an excellent prognosis [9][13]. They rarely spread to other parts of the body. In fact, if they do develop, they are often easily removed right during a standard endoscopy without requiring major surgery [14][9]. Your doctors will track your gastrin levels because extremely high levels can help predict the risk of developing these growths or indicate their presence [7][6][15].

What This Means for Your Care

Because of the link between autoimmune gastritis, high gastrin, and stomach growths, regular monitoring is essential. Your doctor will likely recommend endoscopic surveillance—a procedure where a flexible tube with a camera is used to look inside your stomach and take small tissue samples (biopsies) [16][17][18]. This allows them to keep an eye on the health of your stomach lining and catch any abnormal growths very early [9][19]. During these endoscopies, doctors are looking for gNETs as well as dysplasia, which are early cell changes that could become cancerous if left alone [20][16].

Additionally, because low stomach acid affects how you absorb nutrients, your care team should regularly check your iron and vitamin B12 levels [21][2]. Deficiencies in iron and B12 are very common in people with autoimmune gastritis and can lead to anemia, including a specific type associated with B12 deficiency called pernicious anemia [22].

Finally, your doctors might review any medications you are taking, such as proton pump inhibitors (PPIs) for acid reflux, as these can also raise gastrin levels and might need to be adjusted [23][24][25].

Common questions in this guide

Why does autoimmune gastritis cause high gastrin levels?
In autoimmune gastritis, your immune system mistakenly attacks acid-producing cells in the stomach, leading to very low stomach acid. Your body senses this low acid and pumps out the hormone gastrin in a failed attempt to stimulate more acid production, resulting in high levels on blood tests.
Is a high gastrin level dangerous?
A high gastrin level is not an immediate medical emergency. Instead, it serves as an important diagnostic clue that your stomach is not making enough acid. Doctors use this marker to understand your condition and plan long-term monitoring.
Can acid reflux medications affect my gastrin levels?
Yes, medications like proton pump inhibitors (PPIs) used for acid reflux can further lower stomach acid and cause your body to produce more gastrin. Your care team may review your medications to see if they need to be adjusted.
What are Type 1 gastric neuroendocrine tumors (gNETs)?
Type 1 gNETs are small, slow-growing stomach tumors that can develop when high gastrin levels constantly stimulate certain cells in the stomach over many years. They are generally highly treatable and can often be removed during a standard endoscopy.
Why do I need regular endoscopies if I have high gastrin?
Because high gastrin levels increase the risk of stomach growths, regular endoscopies are essential. This procedure allows your doctor to look inside your stomach, take tissue biopsies, and catch any abnormal cell changes very early.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How often should I have an upper endoscopy to monitor my stomach lining given my high gastrin levels?
  2. 2.Will you be monitoring other blood markers, such as Chromogranin A, alongside my gastrin levels?
  3. 3.Could any of my current medications, such as acid blockers, be contributing to my high gastrin levels?
  4. 4.What specific early changes, like dysplasia or small growths, are you looking for during my endoscopy biopsies?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Do Oral B12 Pills Work for Autoimmune Gastritis?Can Medications Stop Autoimmune Gastritis?Can B12 Deficiency Nerve Damage Be Reversed?Can Autoimmune Gastritis Have Negative Antibodies?How Often to Get an Endoscopy for Autoimmune Gastritis?Is Autoimmune Gastritis Deadly? Risks & Life ExpectancyIs Autoimmune Gastritis Hereditary? | Inciteful MedWhat is Autoimmune Gastritis Commonly Misdiagnosed As?What is ECL Cell Hyperplasia in Autoimmune Gastritis?What Is the Best Diet for Autoimmune Gastritis (AIG)?How Are H. pylori and Autoimmune Gastritis Connected?Gastric NETs vs Stomach Cancer: What's the Difference?What is the Prognosis for Autoimmune Gastritis?Why Does My B12 Shot Schedule Change to Monthly?Why Does Iron Drop Before B12 in Autoimmune Gastritis?Why Iron Supplements Fail in Autoimmune Gastritis

References

References (25)
  1. 1

    Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis.

    Kishikawa H, Nakamura K, Ojiro K, et al.

    Scientific reports 2022; (12(1)):4202 doi:10.1038/s41598-022-07947-1.

    PMID: 35273265
  2. 2

    Pathophysiology and laboratory diagnosis of pernicious anemia.

    Toh BH

    Immunologic research 2017; (65(1)):326-330 doi:10.1007/s12026-016-8841-7.

    PMID: 27538411
  3. 3

    Polyautoimmunity in autoimmune gastritis.

    Kalkan Ç, Soykan I

    European journal of internal medicine 2016; (31()):79-83.

    PMID: 27085391
  4. 4

    Progression From Antral G-Cell Hyperplasia to Gastric Neuroendocrine Tumor in a Patient With Autoimmune Gastritis.

    Brown P, Tetali B, Suresh S, Varma A

    ACG case reports journal 2021; (8(8)):e00649 doi:10.14309/crj.0000000000000649.

    PMID: 34476276
  5. 5

    Prevalence and predictors of colonoscopic findings in patients with autoimmune gastritis.

    Asfuroglu Kalkan E, Kalkan C, Gumussoy M, et al.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2022; (70(1)):73-78 doi:10.1136/jim-2021-001911.

    PMID: 34341100
  6. 6

    Serum Gastrin Levels Are Associated With Prevalent Neuroendocrine Tumors in Autoimmune Metaplastic Atrophic Gastritis.

    Jove A, Lin C, Hwang JH, et al.

    The American journal of gastroenterology 2025; (120(5)):1140-1143 doi:10.14309/ajg.0000000000003235.

    PMID: 39588964
  7. 7

    Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors.

    Magris R, De Re V, Maiero S, et al.

    Clinical and translational gastroenterology 2020; (11(9)):e00238 doi:10.14309/ctg.0000000000000238.

    PMID: 33094954
  8. 8

    Hypergastrinemia Expands Gastric ECL Cells Through CCK2R+ Progenitor Cells via ERK Activation.

    Sheng W, Malagola E, Nienhüser H, et al.

    Cellular and molecular gastroenterology and hepatology 2020; (10(2)):434-449.e1 doi:10.1016/j.jcmgh.2020.04.008.

    PMID: 32330731
  9. 9

    Unmasking the high-risk phenotype in autoimmune gastritis: A pathologist's roadmap for the clinician.

    Wang CL, Zeng M, Luo Y

    World journal of gastroenterology 2025; (31(48)):115244 doi:10.3748/wjg.v31.i48.115244.

    PMID: 41480315
  10. 10

    Gastric Neuroendocrine Tumors (Carcinoids).

    Gluckman CR, Metz DC

    Current gastroenterology reports 2019; (21(4)):13 doi:10.1007/s11894-019-0684-7.

    PMID: 30868284
  11. 11

    Association between autoimmune gastritis and gastric polyps: Clinical characteristics and risk factors.

    Jin JZ, Liang X, Liu SP, et al.

    World journal of gastrointestinal oncology 2025; (17(1)):92908 doi:10.4251/wjgo.v17.i1.92908.

    PMID: 39817144
  12. 12

    Type 1 Gastric Neuroendocrine Tumor Found on Endoscopic Polypectomy.

    Gonzalez HH, Acosta M, Yazji G, Bromer MQ

    Cureus 2019; (11(3)):e4193 doi:10.7759/cureus.4193.

    PMID: 31106093
  13. 13

    Marked Hypergastrinemia with G-cell Hyperplasia in Two Autoimmune Gastritis Patients.

    Watanabe H, Yoneda S, Motoyama Y, et al.

    Internal medicine (Tokyo, Japan) 2020; (59(6)):799-803 doi:10.2169/internalmedicine.3009-19.

    PMID: 31787690
  14. 14

    Single-incision laparoscopic antrectomy for type I gastric neuroendocrine tumor: a case report.

    Kitadani J, Ojima T, Hayata K, et al.

    Surgical case reports 2021; (7(1)):15 doi:10.1186/s40792-021-01109-7.

    PMID: 33433761
  15. 15

    Spurious Elevations of Chromogranin A in the Setting of Autoimmune Metaplastic Atrophic Gastritis.

    Jose E, Ambrosio A, Simon JF, Schneider JH

    Cureus 2026; (18(1)):e102050 doi:10.7759/cureus.102050.

    PMID: 41728546
  16. 16

    Gastric lesions in patients with autoimmune metaplastic atrophic gastritis: a retrospective study in a single center.

    Hu H, Li R, Shao L, et al.

    Scandinavian journal of gastroenterology 2022; (57(11)):1296-1303 doi:10.1080/00365521.2022.2081061.

    PMID: 35645153
  17. 17

    Incidence of Gastric Neoplasms Arising from Autoimmune Metaplastic Atrophic Gastritis: A Systematic Review and Case Reports.

    Chen C, Yang Y, Li P, Hu H

    Journal of clinical medicine 2023; (12(3)) doi:10.3390/jcm12031062.

    PMID: 36769710
  18. 18

    Beyond metaplasia: unraveling the complex pathogenesis of autoimmune atrophic gastritis and its implications for gastric cancer risk.

    Zhang T, Tang X

    QJM : monthly journal of the Association of Physicians 2025; (118(4)):203-247 doi:10.1093/qjmed/hcaf028.

    PMID: 39854274
  19. 19

    Autoimmune Metaplastic Atrophic Gastritis Reporting: Are Pathologists and Endoscopists on the Same Page?

    Vienneau N, Lee H, Zhang X, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(22)) doi:10.3390/diagnostics15222906.

    PMID: 41300931
  20. 20

    Deletion of Men1 and somatostatin induces hypergastrinemia and gastric carcinoids.

    Sundaresan S, Kang AJ, Hayes MM, et al.

    Gut 2017; (66(6)):1012-1021 doi:10.1136/gutjnl-2015-310928.

    PMID: 26860771
  21. 21

    Iron and Vitamin B12 Deficiency in Patients with Autoimmune Gastritis and Helicobacter pylori Gastritis: Results from a Prospective Multicenter Study.

    Osmola M, Chapelle N, Vibet MA, et al.

    Digestive diseases (Basel, Switzerland) 2024; (42(2)):145-153 doi:10.1159/000535206.

    PMID: 38198775
  22. 22

    Graves' disease patients with iron deficiency anemia: serologic evidence of co-existent autoimmune gastritis.

    Gianoukakis AG, Gupta S, Tran TN, et al.

    American journal of blood research 2021; (11(3)):238-247.

    PMID: 34322286
  23. 23

    Enterochromaffin-like Cell Hyperplasia-Associated Gastric Neuroendocrine Tumors May Arise in the Setting of Proton Pump Inhibitor Use.

    Rais R, Trikalinos NA, Liu J, Chatterjee D

    Archives of pathology & laboratory medicine 2022; (146(3)):366-371 doi:10.5858/arpa.2020-0315-OA.

    PMID: 34283890
  24. 24

    Severe Anemia from Multiple Gastric Hyperplastic Polyps in a Hemodialysis Patient after Long-term Use of a Proton-pump Inhibitor.

    Ikeda S, Takahashi T, Tandoh T, et al.

    Internal medicine (Tokyo, Japan) 2024; (63(5)):649-657 doi:10.2169/internalmedicine.2091-23.

    PMID: 38432892
  25. 25

    A case of enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction which was successfully treated with somatostatin analogue.

    Hirai R, Haruma K, Okada H, et al.

    Clinical journal of gastroenterology 2022; (15(2)):363-367 doi:10.1007/s12328-021-01581-6.

    PMID: 34982362

This page is for informational purposes only and does not replace professional medical advice. Always consult your gastroenterologist or care team about your specific lab results, gastrin levels, and endoscopy schedule.

Get notified when new evidence is published on autoimmune gastritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.